Free cash flow · 2019–2025
Bioventus free cash flow
$72.1M+90.8% · FY2025
Bioventus (BVS) reported $72.1M in free cash flow for fiscal 2025, +90.8% year on year.
| Fiscal year | Free cash flow | Change | Filing |
|---|---|---|---|
| FY2025 | $72.1M | +90.8% | Derived |
| FY2024 | $37.8M | +373.4% | Derived |
| FY2023 | $8.0M | +$23.0M | Derived |
| FY2022 | −$15.0M | −$24.5M | Derived |
| FY2021 | $9.5M | −82.8% | Derived |
| FY2020 | $55.2M | +43.9% | Derived |
| FY2019 | $38.4M | — | Derived |
Free cash flow — Free cash flow is operating cash flow minus capital expenditure: what is left once the company has paid to maintain and expand its asset base. We calculate it from two lines in the same filing, and a company is only ranked here if it reported both.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +11.1%
Calculated from two reported figures, so it has no single filing of its own.
Free cash flow at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bioventus free cash flow |url=https://companiesranked.com/en/company/bioventus/free-cash-flow |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bioventus free cash flow. CompaniesRanked. https://companiesranked.com/en/company/bioventus/free-cash-flowBibTeX
@misc{companiesranked-en-company-bioventus-free-cash-flow-2026,
author = {{CompaniesRanked}},
title = {{Bioventus free cash flow}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bioventus/free-cash-flow}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.